Clinical Guides
Chlamydia
A clinically focused guide to asymptomatic and symptomatic Chlamydia trachomatis infection in India, integrating exposure-site NAAT testing, complications, pregnancy and neonatal care, partner services, antimicrobial stewardship and stigma-free follow-up.
MedNext Academy | 14 min read
Chlamydia
A clinically focused guide to asymptomatic and symptomatic Chlamydia trachomatis infection in India, integrating exposure-site NAAT testing, complications, pregnancy and neonatal care, partner services, antimicrobial stewardship and stigma-free follow-up.
Summary
Chlamydia is a curable sexually transmitted infection caused by Chlamydia trachomatis. Urogenital, rectal and oropharyngeal infection may follow exposure at the corresponding anatomical site, and many infections cause no symptoms. The absence of discharge or pain therefore does not exclude infection or prevent transmission. When symptoms occur, cervicitis can cause discharge or postcoital bleeding, urethritis can cause dysuria and discharge, rectal infection can cause pain, bleeding or discharge, and epididymal infection can cause unilateral scrotal pain. Untreated ascending infection can contribute to pelvic inflammatory disease, ectopic pregnancy, chronic pelvic pain and tubal-factor infertility.
Diagnosis is based on nucleic acid amplification testing from a specimen chosen for anatomy and exposure: vaginal swab is generally the preferred urogenital specimen for women, while first-catch urine is commonly preferred for men. Rectal testing must be offered when rectal exposure is relevant; a urine-only strategy misses isolated extragenital infection. Test for gonorrhoea, HIV and syphilis according to risk and presentation. Clinical PID, epididymitis, proctitis, pregnancy-related disease or neonatal infection needs the relevant syndrome pathway, not treatment as uncomplicated chlamydia alone.
Prompt antibiotic treatment, management of recent partners, temporary sexual abstinence and retesting reduce transmission and reinfection. Most repeat positive tests reflect reinfection or incomplete partner treatment rather than antimicrobial resistance. Pregnancy requires a pregnancy-compatible regimen and a test of cure; infants can develop conjunctivitis or an afebrile pneumonia after perinatal exposure. Care must be confidential, consent-based and non-stigmatizing. This draft has been reviewed by the MedNext Clinical Team and does not substitute for the current NACO protocol, local laboratory validation or patient-specific prescribing.
How Common Is It?
Chlamydia is among the most common bacterial sexually transmitted infections globally. WHO estimated 128.5 million new infections in people aged 15 to 49 during 2020, with estimated global prevalence of 4.0% in women and 2.5% in men. These are modelled worldwide estimates anchored to 2020, not current Indian prevalence figures and not a justification to assign risk from sex or age alone. Surveillance counts underestimate infection because symptoms are often absent, testing access is uneven and stigma can deter care.
Young people carry a substantial burden in many datasets, but anyone with relevant sexual exposure can acquire infection. Prevalence varies by population, anatomical site, test method and care setting. Antenatal clinics, STI clinics, community programmes and studies of key populations answer different questions; their percentages should not be combined into a national rate. India lacks a single contemporary population estimate suitable for individual counselling. NACO programme data reflect service use and targeted testing, while many infections outside public STI services are not captured.
The important clinical consequence of common asymptomatic infection is that symptom-triggered testing alone misses cases. Screening policy should be explicit about population, frequency, consent, resources and linkage to treatment. CDC recommends annual testing for all sexually active women younger than 25 and older women at increased risk, but that is US guidance and should not be presented as India's universal national rule. Indian services should follow current NACO, antenatal, institutional and specialty policy. Whatever the programme, a positive result requires reliable treatment, partner services and follow-up; screening without those components has limited value.
Risk Factors
Risk follows exposure to an infected mucosal site rather than identity. New or multiple partners, a partner with another partner or diagnosed STI, inconsistent condom use, previous chlamydia or another STI, and sexual networks with higher background prevalence increase probability. Receptive anal exposure creates rectal risk; oral exposure can create pharyngeal infection, although its clinical significance and prevalence are lower. Age can guide screening programmes but is not a biological guarantee of infection. Ask about anatomy and practices in plain, neutral language so specimen selection is accurate.
Structural risk matters. Limited confidential services, cost, travel, fear of disclosure, criminalization or discrimination, intimate-partner violence and poor access to partner treatment can delay diagnosis or cause reinfection. Adolescents may avoid care if confidentiality is unclear. Men who have sex with men, transgender people, sex workers and people living with HIV may face service barriers; they should not be treated as risk labels without an exposure history. Pregnancy does not prevent acquisition and may create neonatal consequences.
Complication risk rises when infection is untreated or repeated. Cervical infection may ascend to the endometrium and fallopian tubes even when symptoms are mild, and repeat infections add PID risk. Epididymitis can complicate urethral infection. Perinatal exposure can lead to neonatal conjunctivitis or pneumonia. Lymphogranuloma venereum is caused by invasive C. trachomatis serovars and should be considered with proctocolitis, genital ulceration or marked lymphadenopathy in the right epidemiological setting. Antibiotic exposure without testing can obscure coinfection and select resistance in other organisms; it is not a substitute for a complete STI assessment.
Diagnosis
History
Begin with consent, confidentiality and the patient's priority. Ask about dysuria, urethral or vaginal discharge, intermenstrual or postcoital bleeding, pelvic pain, dyspareunia, fever, rectal pain or discharge, genital ulcers and unilateral scrotal pain. Establish last sexual contact, number and gender of partners only as clinically needed, condom use, vaginal, anal and oral exposure sites, previous STI tests and antibiotics. Ask pregnancy possibility, last menstrual period, contraception and safety at home. A partner notification discussion should never expose someone to violence; assess whether direct contact is safe.
Examination
Asymptomatic screening does not require a genital examination. When symptoms exist, assess vital signs and abdominal tenderness, then offer a consented genital, speculum, bimanual, rectal or scrotal examination according to presentation and competence. Cervical friability or mucopurulent discharge supports cervicitis but is neither sensitive nor specific. Cervical motion, uterine or adnexal tenderness raises PID concern and warrants a low treatment threshold. Epididymal tenderness and swelling require exclusion of torsion. Proctitis may include anorectal tenderness, discharge, bleeding or ulcers. Preserve privacy, use a chaperone according to policy and stop if consent is withdrawn.
Investigations
NAAT is the preferred diagnostic method. Use a validated vaginal swab for women when available; self-collection performs comparably to clinician collection on approved platforms. First-catch urine is commonly used for men. Test rectal and, when indicated, pharyngeal sites according to exposure and local assay validation; a negative urine test does not clear an untested rectal site. Test for gonorrhoea, HIV and syphilis, and perform pregnancy testing when it changes management. Do not use NAAT less than four weeks after treatment as a routine test of cure because residual nonviable nucleic acid can cause a positive result. Culture and susceptibility are not routine for chlamydia; investigate persistent disease for adherence, reinfection, site, coinfection and alternative pathogens.
Differential Diagnosis
Gonorrhoea can cause cervicitis, urethritis, proctitis, epididymitis and neonatal eye disease and often coexists with chlamydia; diagnostic testing or syndrome-appropriate dual coverage may be required. Mycoplasma genitalium is an important cause of persistent or recurrent urethritis and cervicitis and is associated with PID. Trichomoniasis, bacterial vaginosis and vulvovaginal candidiasis cause different discharge patterns but symptoms overlap. Urinary tract infection can cause dysuria without genital inflammation. Genital herpes can cause dysuria, ulcers or proctitis, and syphilis requires separate serological assessment.
Pelvic pain demands a broader differential: ectopic pregnancy, appendicitis, ovarian torsion, ruptured cyst, endometriosis and urinary infection can coexist with or mimic PID. A negative chlamydia NAAT does not exclude PID caused by another organism, and a positive NAAT does not prove that every abdominal symptom is PID. Acute scrotal pain requires urgent exclusion of testicular torsion; do not allow an STI assumption to delay surgical assessment. Enteric pathogens, inflammatory bowel disease, haemorrhoids and trauma may mimic proctitis.
Lymphogranuloma venereum differs from uncomplicated infection by invasive disease, often with painful proctocolitis, ulcers or lymphadenopathy, and requires a longer treatment pathway and specialist or public-health input. Reactive arthritis can follow genitourinary infection but septic arthritis and other inflammatory disease must be excluded. In a neonate with conjunctivitis, test for gonorrhoea because it can threaten the eye rapidly; chemical conjunctivitis and other bacteria remain possible. An afebrile infant with staccato cough suggests chlamydial pneumonia, but viral, bacterial, cardiac and congenital causes require age-appropriate assessment.
Management
Treat a confirmed uncomplicated infection promptly and use a current national or institutional regimen. WHO 2024 and NACO guidance support doxycycline for seven days as a first-line option for uncomplicated adult and adolescent infection, with azithromycin as an alternative in defined circumstances. Rectal infection is a reason to prefer doxycycline when safe because comparative evidence favours it. Pregnancy, neonatal disease, PID, epididymitis, proctitis with suspected LGV and severe illness each require a distinct regimen or duration; do not reduce them to the uncomplicated algorithm. Assess adherence barriers before choosing treatment.
Ask the patient to avoid sex for seven days after single-dose treatment or until a seven-day course is complete, symptoms have resolved and partners have been treated. Identify partners from the preceding 60 days for confidential evaluation, testing and presumptive treatment; the most recent partner still needs care if contact was earlier. Partner-delivered therapy is governed by law and programme policy and should not be improvised. Provide written, neutral information that does not identify the index patient. Offer condoms and discuss prevention without implying blame.
Test for HIV, gonorrhoea and syphilis and address hepatitis or PrEP needs according to exposure. Retest the treated patient at about three months because reinfection is common, regardless of whether partners reportedly took treatment. Routine test of cure is unnecessary in most nonpregnant adults if treatment and symptom resolution are reliable. Pregnancy requires NAAT test of cure at about four weeks and retesting at three months; additional antenatal testing follows continuing risk and local policy. Persistent symptoms require examination and targeted testing rather than repeating the same antibiotic automatically.
Prescribing Information
For uncomplicated chlamydia in a nonpregnant adult or adolescent, NACO 2024 lists doxycycline 100 mg orally twice daily for seven days as first line and azithromycin 1 g orally once as an effective substitute. Apply the current verified local protocol, allergy history, pregnancy status, renal and hepatic context, interactions and ability to complete therapy. Doxycycline counselling includes taking with water, remaining upright, separating interacting antacids or mineral supplements and recognising photosensitivity or oesophageal irritation. Avoid relying on a single-dose alternative merely for convenience when rectal infection is known or possible and adherence to doxycycline can be supported.
In pregnancy, NACO lists azithromycin 1 g orally once, amoxicillin 500 mg orally three times daily for seven days, or erythromycin 500 mg orally four times daily for seven days. Verify gestation, local formulary and guideline version before selecting among these options. Doxycycline and ofloxacin are not recommended in pregnancy. Neonatal conjunctivitis or pneumonia requires systemic, weight-based paediatric therapy and follow-up; topical eye treatment alone is inadequate for chlamydial ophthalmia. Macrolide exposure in infants younger than six weeks has been associated with hypertrophic pyloric stenosis, so caregivers need feeding and vomiting safety-netting.
C. trachomatis treatment failure should not automatically be called antimicrobial resistance. More common explanations are reinfection from an untreated partner, incomplete dosing, vomiting, incorrect diagnosis, an untested rectal reservoir or another pathogen such as M. genitalium. Obtain a detailed timeline and specialist advice for genuine persistent infection. Do not use fluoroquinolones, repeated macrolides or prolonged combinations without a defined indication. Stewardship includes site-correct testing, adherence support, partner care and avoidance of unnecessary treatment while not delaying empiric therapy for clinically diagnosed PID or other urgent syndromes.
When to Refer
Refer urgently for suspected ectopic pregnancy, severe pelvic or abdominal pain, peritonism, haemodynamic instability, persistent vomiting, high fever, pregnancy with significant pelvic symptoms, tubo-ovarian abscess concern or failure of outpatient PID management. Acute unilateral scrotal pain is an emergency until testicular torsion has been excluded. Severe proctocolitis, rectal bleeding, genital ulceration with nodes or suspected lymphogranuloma venereum warrants specialist sexual-health or infectious-disease assessment. Sexual assault requires a trauma-informed pathway with forensic, safeguarding, emergency contraception, HIV PEP and hepatitis considerations as appropriate; a chlamydia test alone is insufficient.
Pregnant patients with a positive result need prompt antenatal coordination, pregnancy-compatible treatment, a four-week test of cure and reliable retesting. Communicate a maternal result to the newborn team with consent and safeguarding of confidentiality. Evaluate infants aged 30 days or younger with conjunctivitis promptly and test for both chlamydia and gonorrhoea; urgent ophthalmic input is needed if corneal involvement or gonococcal disease is possible. Infants aged one to three months with afebrile staccato cough, tachypnoea or feeding difficulty need paediatric assessment for chlamydial pneumonia and other causes.
Routine uncomplicated infection can be managed in primary or sexual-health care when validated NAAT, appropriate medicines, partner services and follow-up exist. Refer when testing is unavailable but symptoms persist, when repeated NAAT positivity remains unexplained, when allergy or interactions remove standard options, or when confidentiality, violence or safeguarding concerns complicate partner notification. In India, Suraksha Clinics and NACO-linked services can provide STI pathways, but availability differs. Confirm location, opening, privacy and cost rather than giving a generic referral that the patient cannot use.
Red Flags
In women and people with a uterus, severe or unilateral pelvic pain, shoulder-tip pain, syncope, pregnancy or a positive pregnancy test, guarding, fever or haemodynamic change raises ectopic pregnancy, severe PID or another surgical emergency. Do not wait for a chlamydia result. Milder lower abdominal pain with cervical motion, uterine or adnexal tenderness can still represent PID; delaying treatment can increase reproductive harm. A positive cervical test does not exclude appendicitis, torsion or abscess.
In men and people with testes, sudden severe unilateral scrotal pain, a high-riding testis, nausea or absent cremasteric response requires emergency torsion assessment. Fever, systemic toxicity, marked swelling or abscess concern also needs escalation. In any patient, proctitis with fever, tenesmus, bleeding, ulcers or severe pain suggests invasive infection such as LGV, herpes or another enteric or inflammatory process. Neurological symptoms, disseminated rash or joint swelling with systemic illness are not features of simple uncomplicated chlamydia.
Neonatal red flags are purulent conjunctivitis, eyelid oedema, corneal haze, poor feeding, lethargy, apnoea, tachypnoea or hypoxaemia. Gonococcal ophthalmia can damage the cornea rapidly, so dual evaluation is essential. Pregnancy with untreated infection, inability to tolerate medication or absent follow-up also increases consequence. Finally, disclosure risk is clinical safety: threats, coercion, intimate-partner violence, forced sex, exploitation or concern about a minor require confidential safeguarding procedures. Never pressure direct partner notification when it could provoke harm; use trained services and document the agreed safe plan.
Indian Clinical Context
India's NACO 2024 National Technical Guidelines on STI and RTI combine syndrome-based care with laboratory diagnosis where available. Syndromic treatment can protect a symptomatic patient when testing is inaccessible or follow-up uncertain, but it is not a sensitive screening tool for asymptomatic chlamydia and can overtreat other causes of discharge. When reliable NAAT is available, use it to improve aetiological diagnosis and stewardship. Follow the current NACO tables for uncomplicated infection, cervicitis, urethral discharge, PID, epididymitis and proctitis rather than extracting one medicine from a syndrome.
Access is uneven across public Suraksha Clinics, medical colleges, private laboratories and community services. Confirm whether a platform is validated for vaginal, urine, rectal or pharyngeal specimens; a laboratory offering urine NAAT may not validate extragenital swabs. Self-collected vaginal or rectal specimens can expand privacy and reach when the assay supports them. Results systems should protect confidentiality, use the patient's preferred contact method and avoid revealing STI information in shared household messages. Adolescents and marginalized groups need transparent explanations of consent and safeguarding rules.
A nonjudgmental consultation improves clinical accuracy. Ask behaviours and anatomical exposure rather than marital status, sexual orientation or assumptions. Use local-language counselling, discuss condoms and partner services, and make costs and return dates explicit. NACO guidance is Indian programme authority, while WHO 2024 informs evidence and CDC offers detailed diagnostic and follow-up principles from a US setting. Where recommendations differ, do not silently hybridize them: document which protocol was followed. No national percentage should be claimed from a clinic sample, and a syndrome-colour kit should never replace assessment for pregnancy, torsion, ectopic pregnancy or sexual violence.
NMC Competency Mapping
Chlamydia teaching maps across microbiology genitourinary infection and laboratory diagnosis, dermatology and venereology sexually transmitted disease competencies, obstetrics and gynaecology vaginal discharge, PID, infertility and antenatal care, paediatrics neonatal infection, pharmacology antimicrobial stewardship, and community medicine prevention and partner services. A learner should explain intracellular C. trachomatis biology, distinguish serovars responsible for common genital disease, LGV and trachoma, and choose NAAT specimens according to anatomical exposure. They should understand why asymptomatic infection makes screening different from syndrome management.
Clinical performance includes taking a confidential, inclusive sexual history; obtaining consent for examination; recognising cervicitis, urethritis, PID, epididymitis and proctitis; excluding ectopic pregnancy and torsion; and arranging testing for HIV, syphilis and gonorrhoea. Communication skills include giving a positive result without blame, negotiating a safe partner-notification plan, explaining abstinence and retesting, and assessing violence or exploitation. Prescribing performance requires differentiating uncomplicated infection from pregnancy, PID, LGV and neonatal regimens and checking adherence and interactions.
In the 2024 NMC curriculum, STI teaching is organized under the Dermatology Topic 10 competency set, with additional relevant microbiology and women's-health outcomes. Institutions should verify the exact code and version against the official curriculum ledger before assessment; older web summaries mislabel some codes. This guide supports knowledge and simulated counselling but does not certify specimen collection, pelvic examination, child safeguarding or independent antimicrobial prescribing. Those skills require supervised observation and documented competence.
Key Exam Pearls for NEET PG
C. trachomatis is an obligate intracellular bacterium. Elementary bodies are the infectious extracellular form; reticulate bodies replicate intracellularly. Genital serovars commonly cause urethritis, cervicitis, PID, epididymitis and perinatal infection, while L1 to L3 cause lymphogranuloma venereum. Most infections can be asymptomatic. Untreated upper-tract infection contributes to tubal infertility and ectopic pregnancy; repeat infection compounds risk. Reactive arthritis can follow urethritis. There is no chlamydia vaccine.
NAAT is the test of choice. Preferred urogenital specimens are a vaginal swab for women and first-catch urine for men, subject to platform validation. Sample the rectum or pharynx according to exposure; a negative urine result does not exclude isolated rectal infection. Patient-collected vaginal and rectal swabs can be accurate on validated systems. Do not perform routine NAAT test of cure less than four weeks after treatment because nonviable nucleic acid may persist. Test for gonorrhoea, HIV and syphilis.
For uncomplicated nonpregnant infection, doxycycline for seven days is the current first-line principle, especially for rectal infection; pregnancy requires a compatible regimen such as azithromycin under the applicable protocol. Treat or evaluate recent partners, avoid sex until treatment windows are complete and retest at three months because reinfection is common. Pregnancy requires test of cure at approximately four weeks. Neonatal conjunctivitis classically appears 5 to 12 days after birth; chlamydial pneumonia at one to three months is often afebrile with staccato cough. Topical therapy alone does not treat neonatal chlamydial conjunctivitis.
Frequently Asked Questions
Can chlamydia be present when there are no symptoms at all?
Yes. Asymptomatic infection is common in every sex, which is why exposure-based testing and defined screening programmes matter. A normal examination also does not exclude infection. NAAT should be collected from the relevant anatomical site; testing urine alone can miss an isolated rectal infection.
Why is repeat testing advised after apparently successful treatment?
A new positive result is commonly caused by reinfection from an untreated or new partner rather than drug resistance. Retesting at about three months finds repeat infection and creates another prevention opportunity. Pregnancy additionally requires a test of cure at about four weeks because persistent infection can harm mother and infant.
Does a positive chlamydia result prove that a partner was recently unfaithful?
No. Many infections remain silent and neither the result nor its bacterial load reliably establishes when infection was acquired or from whom. Clinicians should give facts without accusation, support safe confidential partner notification and assess whether disclosure could provoke coercion or violence.
Can neonatal eye drops prevent or cure chlamydial conjunctivitis?
Routine ocular prophylaxis does not reliably prevent chlamydial conjunctivitis, and topical antibiotics alone do not eradicate neonatal infection. Prevention relies on antenatal detection and maternal treatment. A symptomatic infant needs urgent evaluation for chlamydia and gonorrhoea and, when confirmed or strongly suspected, systemic age-appropriate treatment with follow-up.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic